Investor Presentaiton

9. Sample and data (2) IMPACT EVALUATION PMV □ Individual-level data will be collected on socioeconomic background, education, and malaria-related KAP (including prescription practices) □ Business-level data will be collected on shop characteristics, quality of drugs available, case load, anti-malarials and their prices, and revenues and profits Primary health facility □ Data will be collected on human resources, infrastructure, service availability, case load (uncomplicated and severe; age and sex distribution), budget 16

View entire presentation